Why did REDUCE-IT succeed while other trials and compounds failed? Dr. Deedwania explains that it, for the first time, used the appropriate...
Managing Your Practice
Even now, in the era of texting and e-mail, the telephone remains our primary point of contact with new and long-time patients.
A 77-year-old white male with a history of multiple nonmelanoma and melanoma skin cancers presented with an asymptomatic pink plaque on his scalp...
The agency’s approval of Dsuvia comes at a time when the need is great for nonaddictive agents for pain control.
Med Tech Report
First and foremost, providers need confidence in the accuracy of the monitoring equipment, and, thus far, that accuracy has been questionable.
Dr. Kleber “enabled the research careers of a whole new generation of leaders” in addiction medicine.